Corporate_Investor_National Institute of Allergy and Infectious Diseases

National Institute of Allergy and Infectious Diseases (NIAID) conducts fundamental and applied research to gain a comprehensive understanding of infectious, immunological, and allergic diseases, as well as to develop new techniques for their treatment, prevention, and eventual eradication.

Corporate_Investor_Maryland Venture Fund

The Maryland Venture Fund, started in 1994, is a $110M early-stage, evergreen venture capital fund dedicated to funding and growing the next generation of exceptional businesses based in Maryland.

Corporate_Investor_EDF Ventures

EDF has cultivated a deep and productive network.

Corporate_Investor_Astellas Venture Management

Corporate_Investor_Weclikd

Corporate_Investor_OUP (Osage University Partners)

Osage University Partners is a venture capital firm focused on investing in startups that are commercializing university technologies.

Corporate_Investor_Biomedical Advanced Research and Development Authority (BARDA)

The Biomedical Advanced Research and Development Authority (BARDA), within the Office of the Assistant Secretary for Preparedness and Response in the U.

Corporate_Investor_Logos Capital

Logos Capital is a fundamental biotechnology-focused fund that seeks to combine in-house data analytics with scientific and clinical expertise to identify transformative therapies in healthcare.

Corporate_Investor_NRW.BANK

NRW.

Corporate_Investor_Yorkville Advisors

Yorkville Advisors is an investment manager to private, pooled investment funds with an emphasis on financing growth companies through structured debt and equity investments.